Truvada

• (Reuters) - Gilead Sciences Inc said on Monday it has won U.S. approval to market its drug Truvada as a prophylactic treatment to reduce the risk of infection with HIV, the virus that causes AIDS.
(msnbc.com)
• On Monday, the US Food and Drug Administration approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected individuals.
(Boston Globe)
• FOSTER CITY, Calif., Jul 16, 2012 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S.
(comcast.net)
• The Food and Drug Administration on Monday approved Truvada for prevention of HIV infection in HIV-negative people who are at high risk of contracting the disease, the first time a drug has been approved for reducing that risk.
(Baltimore Sun)
• WASHINGTON — The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
(Washington Post)
• WASHINGTON — The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
(Jackson Clarion-Ledger)
• LOS ANGELES — As the U.S.
(The Keene Sentinel)
• Q: How effective is Truvada as a prevention tool? A: Two large clinical trials involving couples and individuals found that Truvada significantly reduced the risk of transmission of HIV from a low of 44% to more than 90%.
(USA Today)
• It combines Gilead's two-in-one drug Truvada with a third medicine called Sustiva from New York-based Bristol-Myers Squibb Co. (BMY) Now ViiV's studies are spurring doctors and Limet to consider which combinations of drugs will work best for patients.
(Bloomberg)